Sara Hedfors Vidlin

Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports

Alem Zekarias, Sarah Watson, Sara Hedfors Vidlin et al. · Drug Safety · 2020 · 40 citations · Full text

Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project

Lucie M. Gattepaille, Sara Hedfors Vidlin, Tomas Bergvall et al. · Drug Safety · 2020 · 27 citations · Full text

A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance

Sara Hult, Daniele Sartori, Tomas Bergvall et al. · Drug Safety · 2020 · 25 citations · Full text

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

Oskar Gauffin, Judith S. Brand, Sara Hedfors Vidlin et al. · Drug Safety · 2023 · 17 citations · Full text

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020

Elena Rocca, Oskar Gauffin, Ruth Savage et al. · Drug Safety · 2021 · 12 citations · Full text